Pharming Group to participate in April investor conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Pharming Group (Nasdaq: PHAR) has announced its participation in two major investor conferences in April 2025:
- Van Lanschot Kempen Life Sciences Conference in Amsterdam, Netherlands (April 2-3, 2025)
- 24th Annual Needham Virtual Healthcare Conference (April 7-10, 2025)
At the Needham conference, CEO Fabrice Chouraqui and CMO Anurag Relan will deliver a presentation on April 8 at 10:15 am ET/16:15 CET. The presentation will be available via live webcast and replay on Pharming's website under the 'Upcoming Events' and 'News' sections. Interested parties can schedule one-to-one meetings with management through Pharming's IR team or conference representatives.
Details
News Market Reaction – PHAR
On Mar 28, the day this news came out, PHAR closed 3.93% below the previous close.
Data tracked by StockTitan Argus for the Mar 28 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Leiden, the Netherlands, March 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of April:
- Van Lanschot Kempen Life Sciences Conference 2025, Amsterdam, NL, April 2-3, 2025
- 24th Annual Needham Virtual Healthcare Conference, April 7-10, 2025
Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, Chief Medical Officer, will present on Tuesday, April 8 at 10:15 am ET/16:15CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.
For more information about these conferences, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Van Lanschot Kempen or Needham representative.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com and find us on LinkedIn.
For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com
FTI Consulting, London, United Kingdom
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.